Joshua R. Disbrow - Nov 6, 2024 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Executive Officer, Director
Signature
/s/ Joshua R. Disbrow
Stock symbol
AYTU
Transactions as of
Nov 6, 2024
Transactions value $
$0
Form type
4
Date filed
11/8/2024, 07:55 PM
Previous filing
Jul 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYTU Employee Stock Option (Right to Buy) Award $0 +38K $0.00 38K Nov 6, 2024 Common Shares 38K $1.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/3 on November 6, 2025, with the remaining options vesting in 24 equal monthly installments beginning December 6, 2025.